Search for: "ACTAVIS" Results 101 - 120 of 1,004
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
9 Mar 2014, 9:31 pm by Patent Docs
• Defendants: Actavis plc; Actavis, Inc.; Watson Laboratories, Inc.; Actavis Pharma, Inc. [read post]
6 Jan 2014, 7:59 pm by Patent Docs
The Intellectual Property Owners Association (IPO) will offer a one-hour webinar entitled "After Actavis: FTC Update" on January 9, 2014 beginning at 2:00 pm (ET). [read post]
3 Mar 2015, 1:55 am
  Indeed, the cross-undertaking was ultimately granted in favour of the Actavis group, the Teva group and Dr Reddy’s Laboratories, in addition to the public bodies. [read post]
10 May 2018, 8:45 am by D Daniel Sokol
Natasha Nayak, Jindal Global Law is Situating Patent Validity in Antitrust's Rule of Reason: Exploring the Bounds of Actavis. [read post]
4 Nov 2013, 9:55 pm by Patent Docs
Actavis sought a cross-undertaking that allowed (i) any company in the Actavis group and (ii) any customer or potential customer... [read post]
1 Apr 2013, 9:59 pm by Patent Docs
Actavis (the caption for what was Federal Trade Commission v. [read post]
13 Dec 2009, 8:14 pm
Actavis Group et al. 1:09-cv-00940; filed December 8, 2009 in the District Court of Delaware • Plaintiffs: Cephalon Inc.; Cephalon France • Defendants: Actavis Group; Actavis Pharma Manufacturing Pvt Ltd.; Actavis Inc. [read post]
12 Jul 2017, 2:30 am by Matrix Legal Support Service
The Supreme Court unanimously allowed Lilly’s appeal, holding that the Actavis products would infringe the Patent in the United Kingdom, and in France, Italy and Spain. [read post]
14 Nov 2008, 3:23 pm
Department of Justice (DOJ) - FDA court action apart from what parent company Actavis Inc. stated in its November 13 press release, "Actavis Comments on Filing of DOJ Complaint". [read post]
13 May 2014, 5:00 am by Gene Quinn
Actavis plc (NYSE: ACT) announced yesterday that it has entered into an agreement with Valeant Pharmaceuticals International (NYSE: VRX) to settle all outstanding patent litigation related to Actavis' generic version of Acanya®... [read post]
13 May 2014, 5:00 am by Gene Quinn
Actavis plc (NYSE: ACT) announced yesterday that it has entered into an agreement with Valeant Pharmaceuticals International (NYSE: VRX) to settle all outstanding patent litigation related to Actavis' generic version of Acanya®... [read post]
28 Jul 2008, 9:31 pm
Earlier this year, Actavis Totowa LLC recalled all lots Digitek because the tablets contained twice the approved level of the active ingredient. [read post]
12 Apr 2015, 7:45 pm by Patent Docs
• Defendants: Actavis Inc.; Actavis Laboratories FL, Inc.; Activis Pharma, Inc.; Watson Laboratories, Inc.; Anda, Inc. [read post]